ONPH OTC
Oncology Pharma Inc.
1W: -25.0%
1M: -55.8%
3M: -40.2%
YTD: +650.0%
1Y: +5900.0%
3Y: -91.7%
5Y: -99.9%
$0.03
-0.01 (-32.28%)
Weekly Expected Move ±55.2%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.8M
52W Range0.0001-0.364
Volume1,004
Avg Volume21,718
Beta-0.13
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOGeorge Malesek
Employees1
SectorFinancial Services
IndustryShell Companies
IPO Date1994-10-31
Websiteoncology-pharma.com
1 Sansome Street
San Francisco, CA 94104
US
San Francisco, CA 94104
US
415-869-1036
About Oncology Pharma Inc.
Oncology Pharma Inc. is a pharmaceutical firm specializing in oncology, dedicated to the development, manufacturing, and commercialization of therapeutic agents. The company has a collaborative and licensing agreement with Kalos Therapeutics Inc. to explore treatment possibilities for the COVID-19 virus. Originally incorporated in 1993, the company was known as SourcingLink.net Inc. until it rebranded as Oncology Pharma Inc. in June 2019. Its operations are based in San Francisco, California.
Latest News
No recent news
Recent Insider Trades
No insider trades found